The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 3, randomized study of pracinostat (PRAN) in combination with azacitidine (AZA) versus placebo in patients ≥18 years with newly diagnosed acute myeloid leukemia (AML) unfit for standard induction chemotherapy (IC).
 
Guillermo Garcia-Manero
No Relationships to Disclose
 
Chun Yew Fong
Honoraria - Amgen; Helsinn Healthcare; Novartis
Consulting or Advisory Role - Celgene; Novartis
Speakers' Bureau - Roche
Research Funding - Amgen
Travel, Accommodations, Expenses - Amgen
 
Adriano Venditti
Consulting or Advisory Role - Celgene; Gilead Sciences; Jazz Pharmaceuticals; Novartis; Pfizer; Sandoz
 
Silvia Mappa
Employment - Helsinn Healthcare
 
Riccardo Spezia
Employment - Helsinn Healthcare
Patents, Royalties, Other Intellectual Property - Helsinn Healthcare
 
Lionel Ades
Consulting or Advisory Role - Celgene; H3 Biomedicine; Novartis
Research Funding - Celgene